News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
621,368 Results
Type
Article (47155)
Company Profile (638)
Press Release (573562)
Multimedia
Podcasts (58)
Webinars (13)
Section
Business (163606)
Career Advice (2393)
Deals (31062)
Drug Delivery (119)
Drug Development (71811)
Employer Resources (141)
FDA (17213)
Job Trends (13545)
News (293694)
Policy (33481)
Tag
Academia (2653)
Academic (1)
Accelerated approval (19)
Adcomms (27)
Allergies (120)
Alliances (45013)
ALS (150)
Alzheimer's disease (1543)
Antibody-drug conjugate (ADC) (248)
Approvals (17356)
Artificial intelligence (491)
Autoimmune disease (96)
Automation (31)
Bankruptcy (306)
Best Places to Work (11200)
BIOSECURE Act (22)
Biosimilars (182)
Biotechnology (405)
Bladder cancer (138)
Brain cancer (54)
Breast cancer (547)
Cancer (4116)
Cardiovascular disease (348)
Career advice (2023)
Career pathing (34)
CAR-T (249)
CDC (49)
Celiac Disease (1)
Cell therapy (658)
Cervical cancer (35)
Clinical research (61130)
Collaboration (1391)
Compensation (680)
Complete response letters (50)
COVID-19 (2799)
CRISPR (79)
C-suite (560)
Cystic fibrosis (127)
Data (5295)
Decentralized trials (2)
Denatured (10)
Depression (116)
Diabetes (437)
Diagnostics (6472)
Digital health (40)
Diversity (8)
Diversity, equity & inclusion (35)
Drug discovery (218)
Drug pricing (180)
Drug shortages (28)
Duchenne muscular dystrophy (207)
Earnings (67942)
Editorial (52)
Employer branding (17)
Employer resources (129)
Events (83739)
Executive appointments (799)
FDA (19964)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (18)
Funding (1277)
Gene editing (173)
Generative AI (47)
Gene therapy (518)
GLP-1 (863)
Government (4884)
Grass and pollen (6)
Guidances (375)
Healthcare (17684)
HIV (46)
Huntington's disease (33)
IgA nephropathy (69)
Immunology and inflammation (181)
Immuno-oncology (28)
Indications (72)
Infectious disease (3043)
Inflammatory bowel disease (172)
Inflation Reduction Act (12)
Influenza (98)
Intellectual property (211)
Interviews (448)
IPO (15218)
IRA (48)
Job creations (2804)
Job search strategy (1668)
Kidney cancer (12)
Labor market (69)
Layoffs (446)
Leadership (33)
Legal (7647)
Liver cancer (87)
Longevity (11)
Lung cancer (568)
Lymphoma (318)
Machine learning (38)
Management (48)
Manufacturing (677)
MASH (139)
Medical device (13525)
Medtech (13561)
Mergers & acquisitions (16779)
Metabolic disorders (1047)
Multiple sclerosis (137)
NASH (10)
Neurodegenerative disease (251)
Neuropsychiatric disorders (66)
Neuroscience (2563)
NextGen: Class of 2025 (6404)
Non-profit (4303)
Now hiring (19)
Obesity (463)
Opinion (265)
Ovarian cancer (140)
Pain (174)
Pancreatic cancer (176)
Parkinson's disease (232)
Partnered (29)
Patents (449)
Patient recruitment (368)
Peanut (55)
People (44932)
Pharmaceutical (117)
Pharmacy benefit managers (28)
Phase I (18378)
Phase II (26524)
Phase III (21066)
Pipeline (3541)
Policy (267)
Postmarket research (2504)
Preclinical (7606)
Press Release (70)
Prostate cancer (216)
Psychedelics (43)
Radiopharmaceuticals (253)
Rare diseases (678)
Real estate (4990)
Recruiting (61)
Regulatory (24795)
Reports (43)
Research institute (2395)
Resumes & cover letters (398)
Rett syndrome (22)
RNA editing (12)
RSV (77)
Schizophrenia (126)
Series A (208)
Series B (158)
Service/supplier (23)
Sickle cell disease (81)
Special edition (22)
Spinal muscular atrophy (153)
Sponsored (42)
Startups (3215)
State (2)
Stomach cancer (19)
Supply chain (95)
Tariffs (91)
The Weekly (48)
Vaccines (990)
Venture capital (54)
Weight loss (308)
Women's health (58)
Worklife (17)
Date
Today (91)
Last 7 days (571)
Last 30 days (2444)
Last 365 days (28583)
2025 (27601)
2024 (33120)
2023 (37236)
2022 (48159)
2021 (52133)
2020 (51147)
2019 (43967)
2018 (33758)
2017 (30915)
2016 (29367)
2015 (33628)
2014 (25223)
2013 (20680)
2012 (22442)
2011 (22733)
2010 (20242)
Location
Africa (813)
Alabama (66)
Alaska (7)
Arizona (207)
Arkansas (13)
Asia (38077)
Australia (6721)
California (9330)
Canada (2769)
China (891)
Colorado (399)
Connecticut (432)
Delaware (293)
Europe (85878)
Florida (1454)
Georgia (324)
Hawaii (2)
Idaho (52)
Illinois (727)
India (57)
Indiana (446)
Iowa (22)
Japan (345)
Kansas (111)
Kentucky (29)
Louisiana (25)
Maine (71)
Maryland (1227)
Massachusetts (6710)
Michigan (277)
Minnesota (514)
Mississippi (6)
Missouri (127)
Montana (27)
Nebraska (20)
Nevada (101)
New Hampshire (78)
New Jersey (2725)
New Mexico (28)
New York (2582)
North Carolina (1303)
North Dakota (9)
Northern California (4331)
Ohio (279)
Oklahoma (17)
Oregon (41)
Pennsylvania (1819)
Puerto Rico (17)
Rhode Island (41)
South America (1072)
South Carolina (57)
South Dakota (1)
Southern California (3650)
Tennessee (151)
Texas (1462)
United States (33885)
Utah (283)
Vermont (1)
Virginia (249)
Washington D.C. (76)
Washington State (771)
West Virginia (4)
Wisconsin (100)
Wyoming (2)
621,368 Results for "cibus us llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Demetra Acquires OrthoFundamentals, LLC, a Leading Provider of Intuitive, Single-Use Solutions for Sacroiliac (SI) Joint Fusion Procedures, and launches a New Global Spine Division
August 4, 2025
·
4 min read
Press Releases
Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany
December 4, 2025
·
2 min read
Press Releases
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
October 21, 2025
·
3 min read
In partnership with PII
Bridging Formulation and Device: Integrated Supply Chain Strategies for U.S. Pharma Manufacturing
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development with drug delivery device design—and leveraging a single‐vendor ecosystem—can deliver significant time, cost, and regulatory advantages for US‑focused drug products, according to industry experts.
December 8, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)
Mustard-derived organic TerraSanteTM focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies; Large scale field trial showed 2 ton per acre yield increase with larger size potatoes and less culls equating to approximately US$5,000 increase in value per acre; and Significant soil health benefit when applied in combination with the current grower standard program.
December 10, 2025
·
6 min read
Press Releases
Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026
August 26, 2025
·
2 min read
Press Releases
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic’s National Hematology Oncology Testing Capabilities
August 24, 2025
·
4 min read
Press Releases
Uniphar announces U.S. expansion, integrating leading companies and appointing new senior leadership
- New integration aligns U.S. operations, unifying RRD BioPharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs under the Uniphar brand. - Mike Ebhardt is appointed President of Uniphar Pharma Services U.S., alongside Cindy Thompson as Vice President of Operations and Transformation.
November 3, 2025
·
1 min read
Press Releases
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual property protection in the world’s largest pharmaceutical market. This allowance fortifies Cardiol’s global intellectual property portfolio, adding to granted and pending patent applications in Europe, Japan, Canada, Australia, and China.
November 13, 2025
·
6 min read
Earnings
GSK Points to ‘Macro Factors’ To Explain US Shingrix Demand Crash
Shingrix sales in the U.S. took a 15% dive in the third quarter. GSK is now the second Big Pharma to report declining vaccine sales, after
Sanofi reported
a similar decline last week.
October 29, 2025
·
2 min read
·
Tristan Manalac
1 of 62,137
Next